Blepharitis causes: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(2 intermediate revisions by the same user not shown)
Line 23: Line 23:
|-
|-
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[irritation|Chemical irritants]], [[mustard gas]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 31: Line 31:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Dermatologic'''
| '''Dermatologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Atopic dermatitis]], [[congenital erythropoietic porphyria]], [[contact dermatitis]], [[dyskeratosis congenita]], [[epidermolysis bullosa]], [[psoriasis]], [[rosacea]], [[seborrheic dermatitis]], [[skin cancer]], [[xeroderma pigmentosum]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Metipranolol]], [[Pramipexole]], [[Travoprost]]
|bgcolor="Beige"| [[Acitretin]], [[apraclonidine]], [[atropine|atropine (systemic)]], [[betaxolol|betaxolol (systemic)]], [[bexarotene|bexarotene (systemic)]], [[brimonidine (ophthalmic)]], [[brinzolamide]], [[cetuximab]], [[clomipramine]], [[difluprednate]], [[dipivefrin]], [[Erythromycin and Benzoyl Peroxide Topical (patient information)|erythromycin and benzoyl peroxide topical (patient information)]], [[fluocinolone|fluocinolone (ophthalmic)]], [[gatifloxacin]], [[gefitinib]], [[iloperidone]], [[ipilimumab]], [[isotretinoin]], [[lansoprazole]], [[lodoxamide tromethamine]], [[loteprednol]], [[methotrexate]], [[metipranolol]], [[mirtazapine]], [[mupirocin]], [[nisoldipine]], [[nitisinone]], [[pegaptanib]], [[pentamidine|pentamidine (oral inhalation)]], [[pramipexole]], [[pregabalin]], [[quetiapine]], [[ranibizumab]], [[rasagiline]], [[saquinavir]], [[tacrolimus (topical)]], [[tiagabine]], [[timolol (ophthalmic)]], [[travoprost]], [[unoprostone]], [[venlafaxine]], [[verteporfin]], [[zaleplon]], [[ziprasidone]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 43: Line 43:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Endocrine'''
| '''Endocrine'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Diabetes]], [[glucagonoma syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 51: Line 51:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
| '''Gastroenterologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Congenital erythropoietic porphyria]], [[Crohn’s disease]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Genetic'''
| '''Genetic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Congenital erythropoietic porphyria]], [[dyskeratosis congenita]], [[epidermolysis bullosa]], [[lipoid proteinosis]], [[myotonic dystrophy]], [[xeroderma pigmentosum]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Hematologic'''
| '''Hematologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Congenital erythropoietic porphyria]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 67: Line 67:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Infectious Disease'''
| '''Infectious Disease'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Demodex]], [[herpes simplex virus infection]], [[HIV]], [[lice]], [[molluscum contagiosum]], [[pediculosis]], [[periorbital cellulitis]], [[phthiriasis]], [[propionibacterium acnes]], [[pseudomonas aeruginosa]], [[staphylococcus aureus]], [[syphilis]], [[varicella zoster]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Musculoskeletal/Orthopedic'''
| '''Musculoskeletal/Orthopedic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|[[Myotonic dystrophy]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Neurologic'''
| '''Neurologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Myotonic dystrophy]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Nutritional/Metabolic'''
| '''Nutritional/Metabolic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|[[Lipoid proteinosis]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 87: Line 87:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Oncologic'''
| '''Oncologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Glucagonoma syndrome]], [[skin cancer]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Ophthalmologic'''
| '''Ophthalmologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Atopic keratoconjunctivitis]], [[chalazion]], [[contact lens]], [[dry eyes]], [[meibomian gland|dysfunctional meibomian glands]], [[periorbital cellulitis]], [[vernal keratoconjunctivitis]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 111: Line 111:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Rheumatology/Immunology/Allergy'''
| '''Rheumatology/Immunology/Allergy'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Allergies]], [[atopic dermatitis]], [[atopic keratoconjunctivitis]], [[graft-versus-host disease|chronic graft-versus-host disease]], [[Sjögren's syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 127: Line 127:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Miscellaneous'''
| '''Miscellaneous'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|[[hygiene|Poor hygiene]]
|-
|-
|}
|}
Line 136: Line 136:
*[[Allergies]]
*[[Allergies]]
*[[Apraclonidine]]
*[[Apraclonidine]]
*[[Atopic dermatitis]] <ref name="pmid17762935">{{cite journal| author=Auw-Haedrich C, Reinhard T| title=[Chronic blepharitis. Pathogenesis, clinical features, and therapy]. | journal=Ophthalmologe | year= 2007 | volume= 104 | issue= 9 | pages= 817-26; quiz 827-8 | pmid=17762935 | doi=10.1007/s00347-007-1608-8 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17762935  }} </ref>
*[[Atopic keratoconjunctivitis]]
*[[Atopic keratoconjunctivitis]]
*[[atropine|Atropine (systemic)]]
*[[atropine|Atropine (systemic)]]
Line 142: Line 143:
*[[Brimonidine (ophthalmic)]]
*[[Brimonidine (ophthalmic)]]
*[[Brinzolamide]]
*[[Brinzolamide]]
*[[Cetuximab]]
*[[Cetuximab]] <ref name="pmid17026793">{{cite journal| author=Dranko S, Kinney C, Ramanathan RK| title=Ocular toxicity related to cetuximab monotherapy in patients with colorectal cancer. | journal=Clin Colorectal Cancer | year= 2006 | volume= 6 | issue= 3 | pages= 224-5 | pmid=17026793 | doi=10.3816/CCC.2006.n.040 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17026793  }} </ref>
*[[Chalazion]]  
*[[Chalazion]]  
*[[irritation|Chemical irritants]]
*[[irritation|Chemical irritants]]
Line 150: Line 151:
*[[Contact dermatitis]]
*[[Contact dermatitis]]
*[[Contact lens]]
*[[Contact lens]]
*[[Crohn’s disease]]
*[[Crohn’s disease]] <ref name="pmid17262200">{{cite journal| author=Yilmaz S, Aydemir E, Maden A, Unsal B| title=The prevalence of ocular involvement in patients with inflammatory bowel disease. | journal=Int J Colorectal Dis | year= 2007 | volume= 22 | issue= 9 | pages= 1027-30 | pmid=17262200 | doi=10.1007/s00384-007-0275-1 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17262200  }} </ref>
*[[Demodex]]
*[[Demodex]]
*[[Diabetes]]
*[[Diabetes]]
Line 156: Line 157:
*[[Dipivefrin]]
*[[Dipivefrin]]
*[[Dry eyes]]
*[[Dry eyes]]
*[[meibomian gland|Dysfunctional meibomian glands]]
*[[meibomian gland|Dysfunctional meibomian glands]] <ref name="pmid8779082">{{cite journal| author=Driver PJ, Lemp MA| title=Meibomian gland dysfunction. | journal=Surv Ophthalmol | year= 1996 | volume= 40 | issue= 5 | pages= 343-67 | pmid=8779082 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8779082  }} </ref>
*[[Dyskeratosis congenita]]
*[[Dyskeratosis congenita]]
*[[Epidermolysis bullosa]]  
*[[Epidermolysis bullosa]]  
Line 165: Line 166:
*[[Glucagonoma syndrome]]
*[[Glucagonoma syndrome]]
*[[Herpes simplex virus infection]]
*[[Herpes simplex virus infection]]
*[[HIV]]
*[[HIV]] <ref name="pmid18711264">{{cite journal| author=Biswas J, Sudharshan S| title=Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. | journal=Indian J Ophthalmol | year= 2008 | volume= 56 | issue= 5 | pages= 363-75 | pmid=18711264 | doi= | pmc=PMC2636142 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18711264  }} </ref>
*[[Iloperidone]]
*[[Iloperidone]]
*[[Ipilimumab]]
*[[Ipilimumab]]
Line 179: Line 180:
*[[Molluscum contagiosum]]
*[[Molluscum contagiosum]]
*[[Mupirocin]]
*[[Mupirocin]]
*[[sulfur mustard|Mustard gas]]
*[[sulfur mustard|Mustard gas]] <ref name="pmid21282998">{{cite journal| author=Karimian F, Zarei-Ghanavati S, A BR, Jadidi K, Lotfi-Kian A| title=Microbiological evaluation of chronic blepharitis among Iranian veterans exposed to mustard gas: a case-controlled study. | journal=Cornea | year= 2011 | volume= 30 | issue= 6 | pages= 620-3 | pmid=21282998 | doi=10.1097/ICO.0b013e3181e16f7c | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21282998  }} </ref>
*[[Myotonic dystrophy]]  
*[[Myotonic dystrophy]]  
*[[Nisoldipine]]  
*[[Nisoldipine]]  
Line 191: Line 192:
*[[Pramipexole]]
*[[Pramipexole]]
*[[Pregabalin]]
*[[Pregabalin]]
*[[Propionibacterium acnes]]
*[[Propionibacterium acnes]] <ref name="pmid3466455">{{cite journal| author=McCulley JP, Dougherty JM| title=Bacterial aspects of chronic blepharitis. | journal=Trans Ophthalmol Soc U K | year= 1986 | volume= 105 ( Pt 3) | issue=  | pages= 314-8 | pmid=3466455 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3466455  }} </ref>
*[[Pseudomonas aeruginosa]]
*[[Pseudomonas aeruginosa]]
*[[Psoriasis]]  
*[[Psoriasis]] <ref name="pmid21550135">{{cite journal| author=Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI| title=Ocular psoriasis. | journal=J Am Acad Dermatol | year= 2011 | volume= 65 | issue= 6 | pages= 1202-12 | pmid=21550135 | doi=10.1016/j.jaad.2010.10.032 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21550135  }} </ref>
*[[Quetiapine]]
*[[Quetiapine]]
*[[Ranibizumab]]
*[[Ranibizumab]]
*[[Rasagiline]]  
*[[Rasagiline]]  
*[[Rosacea]]
*[[Rosacea]] <ref name="pmid17762935">{{cite journal| author=Auw-Haedrich C, Reinhard T| title=[Chronic blepharitis. Pathogenesis, clinical features, and therapy]. | journal=Ophthalmologe | year= 2007 | volume= 104 | issue= 9 | pages= 817-26; quiz 827-8 | pmid=17762935 | doi=10.1007/s00347-007-1608-8 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17762935  }} </ref>
*[[Saquinavir]]
*[[Saquinavir]]
*[[Seborrheic dermatitis]]
*[[Seborrheic dermatitis]] <ref name="pmid17762935">{{cite journal| author=Auw-Haedrich C, Reinhard T| title=[Chronic blepharitis. Pathogenesis, clinical features, and therapy]. | journal=Ophthalmologe | year= 2007 | volume= 104 | issue= 9 | pages= 817-26; quiz 827-8 | pmid=17762935 | doi=10.1007/s00347-007-1608-8 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17762935  }} </ref>
*[[Sjögren's syndrome]]
*[[Sjögren's syndrome]]
*[[Skin cancer]]
*[[Skin cancer]]
*[[Staphylococcus]]
*[[Staphylococcus aureus]] <ref name="pmid3466455">{{cite journal| author=McCulley JP, Dougherty JM| title=Bacterial aspects of chronic blepharitis. | journal=Trans Ophthalmol Soc U K | year= 1986 | volume= 105 ( Pt 3) | issue=  | pages= 314-8 | pmid=3466455 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3466455  }} </ref>
*[[Syphilis]]  
*[[Syphilis]]  
*[[Tacrolimus (topical)]]
*[[Tacrolimus (topical)]]
Line 213: Line 214:
*[[Vernal keratoconjunctivitis]]  
*[[Vernal keratoconjunctivitis]]  
*[[Verteporfin]]  
*[[Verteporfin]]  
*[[Xeroderma pigmentosum]]
*[[Xeroderma pigmentosum]] <ref name="pmid23601806">{{cite journal| author=Brooks BP, Thompson AH, Bishop RJ, Clayton JA, Chan CC, Tsilou ET et al.| title=Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage. | journal=Ophthalmology | year= 2013 | volume= 120 | issue= 7 | pages= 1324-36 | pmid=23601806 | doi=10.1016/j.ophtha.2012.12.044 | pmc=PMC3702678 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23601806  }} </ref>
*[[Zaleplon]]
*[[Zaleplon]]
*[[Ziprasidone]]
*[[Ziprasidone]]

Revision as of 17:44, 25 November 2015

Blepharitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blepharitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blepharitis causes On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blepharitis causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Blepharitis causes

CDC on Blepharitis causes

Blepharitis causes in the news

Blogs on Blepharitis causes

Directions to Hospitals Treating Blepharitis

Risk calculators and risk factors for Blepharitis causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]

Overview

Common causes of blepharitis include seborrheic dermatitis and bacterial infections.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning Chemical irritants, mustard gas
Dental No underlying causes
Dermatologic Atopic dermatitis, congenital erythropoietic porphyria, contact dermatitis, dyskeratosis congenita, epidermolysis bullosa, psoriasis, rosacea, seborrheic dermatitis, skin cancer, xeroderma pigmentosum
Drug Side Effect Acitretin, apraclonidine, atropine (systemic), betaxolol (systemic), bexarotene (systemic), brimonidine (ophthalmic), brinzolamide, cetuximab, clomipramine, difluprednate, dipivefrin, erythromycin and benzoyl peroxide topical (patient information), fluocinolone (ophthalmic), gatifloxacin, gefitinib, iloperidone, ipilimumab, isotretinoin, lansoprazole, lodoxamide tromethamine, loteprednol, methotrexate, metipranolol, mirtazapine, mupirocin, nisoldipine, nitisinone, pegaptanib, pentamidine (oral inhalation), pramipexole, pregabalin, quetiapine, ranibizumab, rasagiline, saquinavir, tacrolimus (topical), tiagabine, timolol (ophthalmic), travoprost, unoprostone, venlafaxine, verteporfin, zaleplon, ziprasidone
Ear Nose Throat No underlying causes
Endocrine Diabetes, glucagonoma syndrome
Environmental No underlying causes
Gastroenterologic Congenital erythropoietic porphyria, Crohn’s disease
Genetic Congenital erythropoietic porphyria, dyskeratosis congenita, epidermolysis bullosa, lipoid proteinosis, myotonic dystrophy, xeroderma pigmentosum
Hematologic Congenital erythropoietic porphyria
Iatrogenic No underlying causes
Infectious Disease Demodex, herpes simplex virus infection, HIV, lice, molluscum contagiosum, pediculosis, periorbital cellulitis, phthiriasis, propionibacterium acnes, pseudomonas aeruginosa, staphylococcus aureus, syphilis, varicella zoster
Musculoskeletal/Orthopedic Myotonic dystrophy
Neurologic Myotonic dystrophy
Nutritional/Metabolic Lipoid proteinosis
Obstetric/Gynecologic No underlying causes
Oncologic Glucagonoma syndrome, skin cancer
Ophthalmologic Atopic keratoconjunctivitis, chalazion, contact lens, dry eyes, dysfunctional meibomian glands, periorbital cellulitis, vernal keratoconjunctivitis
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy Allergies, atopic dermatitis, atopic keratoconjunctivitis, chronic graft-versus-host disease, Sjögren's syndrome
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Poor hygiene

Causes in Alphabetical Order

The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3

References

  1. ↑ Lemp MA, Nichols KK (2009). "Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment". Ocul Surf. 7 (2 Suppl): S1–S14. PMID 19383269.
  2. ↑ 2.0 2.1 Bernardes TF, Bonfioli AA (2010). "Blepharitis". Semin Ophthalmol. 25 (3): 79–83. doi:10.3109/08820538.2010.488562. PMID 20590417.
  3. ↑ 3.0 3.1 3.2 McCulley JP, Dougherty JM (1986). "Bacterial aspects of chronic blepharitis". Trans Ophthalmol Soc U K. 105 ( Pt 3): 314–8. PMID 3466455.
  4. ↑ 4.0 4.1 4.2 Auw-Haedrich C, Reinhard T (2007). "[Chronic blepharitis. Pathogenesis, clinical features, and therapy]". Ophthalmologe. 104 (9): 817–26, quiz 827-8. doi:10.1007/s00347-007-1608-8. PMID 17762935.
  5. ↑ Dranko S, Kinney C, Ramanathan RK (2006). "Ocular toxicity related to cetuximab monotherapy in patients with colorectal cancer". Clin Colorectal Cancer. 6 (3): 224–5. doi:10.3816/CCC.2006.n.040. PMID 17026793.
  6. ↑ Yilmaz S, Aydemir E, Maden A, Unsal B (2007). "The prevalence of ocular involvement in patients with inflammatory bowel disease". Int J Colorectal Dis. 22 (9): 1027–30. doi:10.1007/s00384-007-0275-1. PMID 17262200.
  7. ↑ Driver PJ, Lemp MA (1996). "Meibomian gland dysfunction". Surv Ophthalmol. 40 (5): 343–67. PMID 8779082.
  8. ↑ Biswas J, Sudharshan S (2008). "Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome". Indian J Ophthalmol. 56 (5): 363–75. PMC 2636142. PMID 18711264.
  9. ↑ Karimian F, Zarei-Ghanavati S, A BR, Jadidi K, Lotfi-Kian A (2011). "Microbiological evaluation of chronic blepharitis among Iranian veterans exposed to mustard gas: a case-controlled study". Cornea. 30 (6): 620–3. doi:10.1097/ICO.0b013e3181e16f7c. PMID 21282998.
  10. ↑ Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI (2011). "Ocular psoriasis". J Am Acad Dermatol. 65 (6): 1202–12. doi:10.1016/j.jaad.2010.10.032. PMID 21550135.
  11. ↑ Brooks BP, Thompson AH, Bishop RJ, Clayton JA, Chan CC, Tsilou ET; et al. (2013). "Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage". Ophthalmology. 120 (7): 1324–36. doi:10.1016/j.ophtha.2012.12.044. PMC 3702678. PMID 23601806.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Blepharitis_causes&oldid=1190358"